TRAX
First Tracks BiotherapeuticsNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$777.68M
P/E Ratio
—
EPS
$-4.71
Beta
—
52W High
$26.80
52W Low
$11.30
50-Day MA
$21.43
200-Day MA
$21.43
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About First Tracks Biotherapeutics
None
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $-139.61M |
| EBITDA | $-178.45M |
| Operating Margin | 0.00% |
| Return on Equity | -48.90% |
| Return on Assets | -29.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | — |
| Price-to-Book | 1.98 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $34.75M |
| Float | 0 |
| % Insiders | 0.00% |
| % Institutions | 27.08% |
Analyst Ratings
Consensus ($35.40 target)
2
Strong Buy4
BuyMore HEALTHCARE Stocks
Data last updated: 5/5/2026